VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.2502
-0.0097 (-3.73%)
Feb 5, 2026, 3:39 PM EST - Market open
VolitionRx Employees
VolitionRx had 75 employees as of September 30, 2025. The number of employees decreased by 21 or -21.88% compared to the same quarter last year.
Employees
75
Change
-21
Growth
-21.88%
Revenue / Employee
$19,627
Profits / Employee
-$305,061
Market Cap
32.77M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Sep 30, 2025 | 75 | -21 | -21.88% | 75 | 0 |
| Jun 30, 2025 | 70 | -31 | -30.69% | 70 | 0 |
| Mar 31, 2025 | 82 | -26 | -24.07% | 82 | 0 |
| Dec 31, 2024 | 85 | -25 | -22.73% | 85 | 0 |
| Sep 30, 2024 | 96 | -18 | -15.79% | 96 | 0 |
| Jun 30, 2024 | 101 | -10 | -9.01% | 101 | 0 |
| Mar 31, 2024 | 108 | 4 | 3.85% | 108 | 0 |
| Dec 31, 2023 | 110 | 6 | 5.77% | 110 | 0 |
| Sep 30, 2023 | 114 | 15 | 15.15% | 114 | 0 |
| Jun 30, 2023 | 111 | 12 | 12.12% | 111 | 0 |
| Dec 31, 2022 | 104 | 21 | 25.30% | 104 | 0 |
| Jun 30, 2022 | 99 | - | - | 99 | 0 |
| Dec 31, 2021 | 83 | 18 | 27.69% | 83 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| TELA Bio | 209 |
| Myomo | 185 |
| Cytosorbents | 149 |
| Baird Medical Investment Holdings | 143 |
| electroCore | 73 |
| IceCure Medical | 66 |
| Pulsenmore | 58 |
| Modular Medical | 54 |
VNRX News
- 1 day ago - Volition Sponsors Symposium at 15th Conference of the European Hidradenitis Suppurativa Foundation - PRNewsWire
- 6 days ago - VolitionRx Limited Announces the Preparation of Reimbursement Submission for its Nu.Q® Cancer Assays - PRNewsWire
- 9 days ago - Volition Announces Data to Support Use of Nu.Q® NETs in New Indication - PRNewsWire
- 16 days ago - Volition Continues to Extend Access to Nu.Q® Vet Cancer Test - PRNewsWire
- 20 days ago - Volition Sponsors Symposium at Veterinary Meeting and Expo - PRNewsWire
- 4 weeks ago - VolitionRx Secures $2.0 Million in Funding - PRNewsWire
- 4 weeks ago - VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats - PRNewsWire
- 7 weeks ago - Volition Issues Business Review 2025 - PRNewsWire